Aclaris is a top competitor of Prollenium. Aclaris is a Public company that was founded in 2012 in Wayne, Pennsylvania. Aclaris operates in the Pharmaceuticals industry. Compared to Prollenium, Aclaris has 60 fewer employees.
Prollenium VS LEO Pharma
LEO Pharma is seen as one of Prollenium's biggest rivals. LEO Pharma was founded in 1908, and is headquartered in Ballerup, Capital Region. LEO Pharma is in the Pharmaceuticals industry. LEO Pharma generates $1.7B more revenue vs. Prollenium.
Prollenium VS Incyte
Incyte is seen as one of Prollenium's top competitors. Incyte was founded in Wilmington, Delaware} in 2002. Incyte competes in the Pharmaceuticals industry. Compared to Prollenium, Incyte generates $5.8B more revenue.
Dermata Therapeutics, Inc. (DRMA) announced financial results for the second quarter ended June 30, 2026, alongside a corporate update highlighting its...
(RTTNews) - Galderma (GALD.SW) announced that Restylane Shaype has been approved in the EU under the Medical Device Regulation for temporary augmentati...
Almirall, S.A. (ALM), a global biopharmaceutical company dedicated to medical dermatology based in Barcelona, announced a collaboration and licensing a...
Generali Investments Management Co LLC grew its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 17.3% during the second quarter, according to its mo...
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 10, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Rege...
BioMarin's discontinued drug showed biomarker benefits in a Phase 3 study for ENPP1 deficiency but these failed to translate to clinical improvements....
- Dermata announced the launch date of its first commercial product, Tome Foundational Treatment, expected on August 25, 2026 -- Dermata recently atten...
Amgen will open a new science and innovation center in Hyderabad's Genome Valley. This facility is expected to become operational by the year 2027. The...